title: Cholesterol accumulation in tissues of the Niemann-pick type C mouse is determined by the rate of lipoprotein-cholesterol uptake through the coated-pit pathway in each organ.
abstract: Niemann-Pick type C (NPC) disease is associated with the accumulation of unesterified cholesterol in nearly all tissues and with progressive neurodegeneration. A murine model of this disease, the NPC mouse, was used to determine whether this sequestered cholesterol represented sterol carried in low density lipoprotein (LDL) and chylomicrons (CMs) taken up into the tissues through the coated-pit pathway. By 7 weeks of age, the sterol pool in the NPC mice had increased from 2,165 to 5,669 mg/kg body weight because of the daily sequestration of 67 mg of cholesterol per kg in the various organs. This was 7-fold greater than the rate of accumulation in control mice. The rate of LDL clearance in the NPC mouse was normal (523 ml/day per kg) and accounted for the uptake of 78 mg/day per kg of cholesterol in LDL whereas 8 mg/day per kg was taken up from CMs. Deletion of the LDL receptor in NPC mice altered the concentration of unesterified cholesterol in every organ in a manner consistent with the changes also observed in the rate of LDL cholesterol uptake in those tissues. Similarly, altering the flow of cholesterol to the liver through the CM pathway changed the concentration of unesterified cholesterol in that organ. Together, these observations strongly support the conclusion that, in NPC disease, it is cholesterol carried in LDL and CMs that is sequestered in the tissues and not sterol that is newly synthesized and carried in high density lipoprotein.
authors.affiliation: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75235-8887, USA.
authors.forename: C
authors.initials: C
authors.lastname: Xie
authors.forename: S D
authors.initials: SD
authors.lastname: Turley
authors.forename: J M
authors.initials: JM
authors.lastname: Dietschy
mesh_terms: D000311:Adrenal Glands / Q000378:metabolism; D000818:Animals; D008076:Cholesterol, HDL / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics; D008078:Cholesterol, LDL / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics*; D002914:Chylomicrons / Q000378:metabolism; D003034:Coated Pits, Cell-Membrane / Q000378:metabolism*; D005260:Female; D005838:Genotype; D047908:Intracellular Signaling Peptides and Proteins; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008817:Mice, Mutant Strains; D000077296:Niemann-Pick C1 Protein; D009542:Niemann-Pick Diseases / Q000235:genetics / Q000378:metabolism*; D011506:Proteins / Q000235:genetics; D013154:Spleen / Q000378:metabolism; D013261:Sterols / Q000378:metabolism; D014018:Tissue Distribution
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D002914:Chylomicrons; D047908:Intracellular Signaling Peptides and Proteins; D000077296:Niemann-Pick C1 Protein; C106831:Npc1 protein, mouse; D011506:Proteins; D013261:Sterols